Clinical Trials Directory

Trials / Unknown

UnknownNCT01737918

Treatment of Urge Urinary Incontinence in Women After Failure of Cesa or Vasa

Phase 1/2 Study of the Effect of TOT or Solifenacin After Cesa or Vasa on Urge Urinary Incontinence

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Klinikum der Universität Köln · Academic / Other
Sex
Female
Age
40 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Urge urinary incontinence can be a disorder caused by destroyed pelvic structures. We repaired the uteri-sacral ligaments (USL) by cesa or vasa. The study evaluates if solifenacin can lead to continence after surgery or if also the pubo-urethral ligaments (PUL) need to be repaired.

Detailed description

It was hypothesized that urge urinary incontinence in women is based on the destruction of the uteri-sacral ligaments (USL)and the pubourethral ligaments (PUL). In a preliminary study (URGE I) we repaired the USL by cesa or vasa. Those patients who are still incontinent after cesa and vasa get the repair of the PUL by means of trans-obturator tapes (TOT). That treatment is compared to conservative medical treatment. Cross over after completion of three months is possible if no continence is achieved.

Conditions

Interventions

TypeNameDescription
PROCEDURETOT
DRUGsolifenacin

Timeline

Start date
2013-01-01
Primary completion
2017-12-01
Completion
2018-07-01
First posted
2012-11-30
Last updated
2015-04-07

Locations

2 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT01737918. Inclusion in this directory is not an endorsement.